|
|
|
|
 |
|
|
|
|
|
| 1. Translational Research |
| - |
Expand program priorities to include additional diseases of importance, such as tuberculosis and emerging respiratory viruses |
| - |
Extend field research into additional countries of Asia and Africa |
| - |
Initiate a vaccine evaluation unit in the Clinical Trials Center of Seoul National University |
| |
|
|
| |
| 2. Laboratory Research and Vaccine Development |
| - |
Enlarge the laboratory programs on immunology, molecular microbiology, and chemistry |
| - |
Create a laboratory of molecular virology to detect and characterize emerging viruses |
| - |
Establish improved tests for evaluating immunological responses to vaccines in children in developing countries |
| - |
Develop methods for molecular characterization of known bacterial pathogens under field conditions |
| - |
Develop new or improved vaccines against Shigella, cholera, and typhoid |
| - |
Facilitate technology transfer of production of new vaccines to qualified producers |
| |
|
|
| |
| 3. Training and Information Dissemination |
| - |
Participate in training in vaccine production and regulation as part of the WHO Global Training Network |
| - |
Organize periodic courses on the clinical evaluation of vaccines, Good Clinical Practices for vaccine trials, computerized approaches to data |
| - |
management, and the design and conduct of economic, sociobehavioral, and policy analyses of vaccine introduction |
| - |
Conduct national and international symposia and workshops on scientific topics of relevance to vaccines for developing |
|
| |
| |
| |
|
|
|
|
